CD44 knockdown inhibited GSCs’ migration and invasion both in vitro and in vivo [17]; mouse brain tumors generated from CD44-knockdown GSCs were less invasive and mice survived significantly longer than control mice [18]. The gene discussed is CD44; the disease is brain neoplasm.